Zobrazeno 1 - 10 of 126 pro vyhledávání: '"William B. Slayton"'
1
Akademický článek
Primary pulmonary artery sarcoma in the pediatric patient: Review of literature and a case report
Autor: Yong Yean Kim, MD, PhD, Tung Thanh Wynn, MD, John David Reith, MD, William B. Slayton, MD, Joanne Lagmay, MD, John Fort, MD, Dhanashree Abhijit Rajderkar, MD
Publikováno v: Radiology Case Reports, Vol 15, Iss 7, Pp 1110-1114 (2020)
Primary pulmonary artery sarcoma (PAS) is extremely rare in children. Nevertheless, distinguishing primary PAS from pulmonary embolism is critical to a child's survival. Primary PAS is commonly misdiagnosed as a pulmonary embolism due to similar pres
Externí odkaz: https://doaj.org/article/d730722ffba2461eaa06f2d2667c6987
Zobrazit plný text záznamu
2
Akademický článek
Irradiating Residual Disease to 30 Gy with Proton Therapy in Pediatric Mediastinal Hodgkin Lymphoma
Autor: Bradford S. Hoppe, Raymond B. Mailhot Vega, Nancy P. Mendenhall, Eric S. Sandler, William B. Slayton, Howard Katzenstein, Michael J. Joyce, Zuofeng Li, Stella Flampouri
Publikováno v: International Journal of Particle Therapy, Vol 6, Iss 4, Pp 1-6 (2020)
Background: Local relapse is a predominant form of recurrence among pediatric patients with Hodgkin lymphoma (PHL). Although PHL radiotherapy doses have been approximately 20 Gy, adults with Hodgkin lymphoma receiving 30 to 36 Gy experience fewer in-
Externí odkaz: https://doaj.org/article/e8df6e5ee94843579f76659bc71100d5
Zobrazit plný text záznamu
3
Akademický článek
Two novel RUNX1 mutations in a patient with congenital thrombocytopenia that evolved into a high grade myelodysplastic syndrome
Autor: Jessica M. Schmit, Daniel J. Turner, Robert A. Hromas, John R. Wingard, Randy A. Brown, Ying Li, Marilyn M. Li, William B. Slayton, Christopher R. Cogle
Publikováno v: Leukemia Research Reports, Vol 4, Iss 1, Pp 24-27 (2015)
Here we report two new RUNX1 mutations in one patient with congenital thrombocytopenia that transformed into a high grade myelodysplastic syndrome with myelomonocytic features. The first mutation was a nucleotide base substitution from guanine to ade
Externí odkaz: https://doaj.org/article/e7e90398f7fd46e3850b777a48c9ca9f
Zobrazit plný text záznamu
5
Irradiating Residual Disease to 30 Gy with Proton Therapy in Pediatric Mediastinal Hodgkin Lymphoma
Autor: Michael Joyce, Eric Sandler, William B. Slayton, Raymond B. Mailhot Vega, Bradford S. Hoppe, Zuofeng Li, Nancy P. Mendenhall, S. Flampouri, Howard M. Katzenstein
Publikováno v: International Journal of Particle Therapy, Vol 6, Iss 4, Pp 1-6 (2020)
International Journal of Particle Therapy
Background Local relapse is a predominant form of recurrence among pediatric patients with Hodgkin lymphoma (PHL). Although PHL radiotherapy doses have been approximately 20 Gy, adults with Hodgkin lymphoma receiving 30 to 36 Gy experience fewer in-f
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94984086e3e315479b47c1705d78e580
https://theijpt.org/doi/pdf/10.14338/IJPT-19-00077.1
Zobrazit plný text záznamu
8
Functional Improvement of Chimeric Antigen Receptor Through Intrinsic Interleukin-15Rα Signaling
Autor: Lung-Ji Chang, Lujia Dong, Shih-Ting Tsao, Yuchen Liu, Wei Zhu, Jan S. Moreb, Sushmita Nair, William B. Slayton, Jing-Bo Wang
Publikováno v: Current Gene Therapy. 19:40-53
Introduction: Recent studies on CD19-specific chimeric antigen receptor (CAR)-modified T cells (CARTs) have demonstrated unprecedented successes in treating refractory and relapsed B cell malignancies. The key to the latest CART therapy advances can
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5418aa893c671c30dff52e01920b68e
https://doi.org/10.2174/1566523218666181116093857
Zobrazit plný text záznamu
9
Eating behaviors and dietary quality in childhood acute lymphoblastic leukemia survivors
Autor: Stefania Pinto, William B. Slayton, Marie L. Chardon, David M. Janicke, Rachel S. Fisher
Publikováno v: Pediatric Blood & Cancer. 68
Background Childhood acute lymphoblastic leukemia (ALL) survivors' increased risk for adverse health outcomes could be mitigated through consuming a balanced diet. Nonetheless, >70% of adult survivors do not meet survivorship dietary recommendations.
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16386509e36ada26b2e4d2afd32ca670
https://doi.org/10.1002/pbc.28811
Zobrazit plný text záznamu
10
Incidence and Risk Factors for 30-Day Readmission after Inpatient Chemotherapy among Acute Lymphoblastic Leukemia Patients
Autor: Phuong T. Tran, William B. Slayton, Mansi Dalal, Joshua D. Brown
Publikováno v: Healthcare
Volume 8
Issue 4
Healthcare, Vol 8, Iss 401, p 401 (2020)
Chemotherapy for acute lymphoblastic leukemia (ALL) patients is complex and intense, resulting in a high readmission rate. We aimed to identify the incidence, causes, and risk factors of readmission following inpatient chemotherapy among ALL patients
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca380071e2627d85bbcdb9faa452aea9
http://europepmc.org/articles/PMC7720128
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje